Tailwind Capital has announced it has closed its third fund, Tailwind Capital Partners III, at $1.8 billion of commitments.
Tailwind indicated the funding will be used to continue the firm’s existing investment strategy.
Based in New York, Tailwind is a middle-market private equity firm focused on growth-oriented investments within healthcare and a few other sectors. The firm primarily targets companies with enterprise values up to $250 million. Current healthcare companies in its portfolio include Abode Healthcare (which was an investment from the new fund), Cumberland Consulting Group, Edenbridge Pharmaceuticals and National HME.